Stay updated with breaking news from Ann Hematol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hemoglobin levels, transfusion independence, and low serum erythropoietin levels were all deemed to have a statistically significant relationship with erythropoiesis-stimulating agent (ESA) response.
Takeda Will Be Protagonist's Co-Development, U.S. Co-Commercialization Partner With 50:50 Profit Share, and With Exclusive Ex-U.S. Global Rights to Commercialize Rusfertide, Protagonist's Investigational Injectable Hepcidin Mimetic Currently in Development for the Treatment of Polycythemia Vera (PV)Takeda Will Make...
Tumor lysis syndrome is an oncologic emergency that every clinician will likely encounter at one time or another, and managing it requires careful consideration of a number of factors.
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy Nearly all myelofibrosis patients are estimated to develop...
PV&ME™ campaign features personal stories from people living with PV and their journeys navigating the rare blood cancerBURLINGTON, Mass. & EAST LANSING, Mich.--(BUSINESS WIRE)--PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TPEx:6446), a global biopharmaceutical innovator based in Taiwa...